Peripheral Neuropathy Caused by Chemical Agents

References

• Sharkey S. J. On peripheral neuritis. Br. Med. J. 1896; 1: 457
   Google Scholar
• Peters R. A. Lethal synthesis. Proc. R. Soc. Lond. (Biol) 1952; 139: 143
   PubMed Web of Science ®Google Scholar
• Albert A. Selective Toxicity, 4th ed. Methuen, London 1968
   Google Scholar
• Cavanagh J. B., Passingham R. J., Vogt J. A. Staining of sensory and motor nerves in muscles with Sudan black B. J. Pathol. Bacteriol. 1964; 88: 89
   PubMedGoogle Scholar
• Glees P., Marsland T. A. Degeneration of pyramidal fibres studied by a paraffin silver method. J. Physiol. (Lond.) 1952; 118: 51p
   Google Scholar
• Armstrong J., Stephens P. R. A modified chrome-silver paraffin-wax technique for staining neural end-feet. Stain Technol. 1960; 35: 71
   PubMed Web of Science ®Google Scholar
• Young J. Z. Functional repair of nervous tissue. Physiol. Rev. 1942; 22: 318
   Google Scholar
• Guth L. Regeneration in the mammalian peripheral nerve. Physiol. Rev. 1956; 36: 441
   PubMed Web of Science ®Google Scholar
• Nicholas J. S. Experimental approaches to problems of early development in the rat. Q. Rev. Biol. 1947; 22: 179
   PubMed Web of Science ®Google Scholar
• Sperry R. W., Hibberd E. Regulative factors in the orderly growth of retinotectal connexions. Growth of the Nervous System, G. W. E. Wolstenholme, M. O'Connor. J. & A. Churchill, London 1968; 41
   Google Scholar
• Gaze R. M. Growth and differentiation. Annu. Rev. Physiol. 1967; 29: 59
   PubMed Web of Science ®Google Scholar
• Chambers W. W., Liu C-N. Fate of cells of Clarke's nucleus following axon section in cat with evidence of spinal collaterals from dorsal spinocerebellar tract. Anat. Rec. 1953; 115: 342
   Google Scholar
• Watson W. E. An autoradiographic study of the incorporation of nucleic-acid precursors by neurones and glia during nerve regeneration. J. Physiol. (Lond.) 1965; 180: 741
   Google Scholar
• Watson W. E. Observations on the nucleolar and total cell body nucleic acid of injured nerve cells. J. Physiol. (Lond) 1968; 196: 655
   Google Scholar
• Torvik A., Skjörten F. Electron microscopic observations on nerve cell regeneration and degeneration after axon lesions. Acta Neuropathol. (Berl) 1971; 17: 248
   PubMed Web of Science ®Google Scholar
• Pannese E. Investigations on the ultrastructural changes of the spinal ganglion neurons in the course of axon regeneration and cell hypertrophy. I. Changes during axon regeneration. Z. Zellforsch. Mikrosk. Anat. 1963; 60: 711
   PubMedGoogle Scholar
• Brattgard S-O., Edström J. E., Hyden H. The chemical changes in regenerating neurones. J. Neurochem. 1957; 1: 316
   PubMed Web of Science ®Google Scholar
• Watson W. E. The response of motor neurones to intramuscular injection of botulinum toxin. J. Physiol. (Lond.) 1969; 202: 611
   Google Scholar
• Davies D. R. Neurotoxicity of organophosphorus compounds. Handbuch der Experimentellen Pharmakologie, Ergänzungwerk, G. B. Koelle. Springer-Verlag, Berlin 1963; Vol. XV, chap. 19
   Google Scholar
• Cavanagh J. B. The significance of the “dying back” process in experimental and human neurological disease. Int. Rev. Exp. Pathol. 1964; 3: 219
   PubMedGoogle Scholar
• O'Brien R. D. Toxic Phosphorus Esters. Academic Press, New York 1960
   Google Scholar
• Valaer P. J. Adulterated ginger—responsible for recent paralysis epidemic. J. Am. Pharm. Assoc. 1930; 19: 948
   Google Scholar
• Vonderahe A. R. Pathological changes in paralysis caused by drinking Jamaica ginger. Arch. Neurol. Psychiatr. (Chicago) 1931; 25: 29
   Google Scholar
• Burley B. T. Polyneuritis from tri-ortho -cresyl phosphate. J. A. M. A. 1931; 98: 298
   Google Scholar
• Smith M. T., Elvove E., Valaer P. J., Frazier W. H., Mallory G. E. Pharmaceutical and chemical studies of the causes of the so-called ginger jake paralysis. Public Health Rep. 1930; 45: 1703
   PubMedGoogle Scholar
• Smith H., Spalding J. M. K. Outbreak of paralysis in Morocco due toortho -cresyl phosphate poisoning. Lancet 1959; 2: 1019
   PubMed Web of Science ®Google Scholar
• Geoffroy H., Slomic A., Benebadji M., Pascal P. Myelo-polynevrites tri-cresyl phosphates. World Neurol. 1960; 1: 294
   PubMedGoogle Scholar
• Bidstrup P. L., Bonnell J. A., Beckett A. G. Paralysis following poisoning by a new organic phosphorus insecticide (mipafox). Br. Med. J. 1953; 1: 1068
   PubMed Web of Science ®Google Scholar
• Svennilson E. Studies of triortho cresyl phosphate neuropathy, Morocco, 1960. Acta Psychiatr. Neurol. Scand. Suppl. 1961; 150: 36, 334
   Google Scholar
• Bjorklund N. E., Erne K., Hallgren W., Sevelius F. Trixylylfosfat som forgiftmingsorsak hos kov. Nord. Vet. Med. 1961; 5: 225
   Google Scholar
• Smith M. I., Lillie R. D. The histopathology of triorthoocresyl phosphate poisoning. Arch. Neurol. Psychiatr. (Chicago) 1931; 26: 976
   Google Scholar
• Cavanagh J. B. The toxic effects of tri-ortho-cresyl phosphate poisoning on the nervous system. J. Neurol. Neurosurg. Psychiatry 1954; 17: 163
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B. Peripheral nerve changes inortho-cresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 1964; 87: 365
   PubMedGoogle Scholar
• Cavanagh J. B., Patangia G. N. Changes in the central nervous system in the cat as the result of tri-o-cresyl phosphate poisoning. Brain 1965; 88: 165
   PubMed Web of Science ®Google Scholar
• Bischoff A. Ultrastructure of triorthocresyl phosphate poisoning in the chicken. II. Studies on spinal cord alterations. Acta Neuropathol. (Berl.) 1970; 15: 142
   PubMed Web of Science ®Google Scholar
• Prineas J. The pathogenesis of dying back polyneuropathies. Part I. An ultrastructural study of experimental tri-ortho-ctesyl phosphate intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969; 28: 571
   PubMed Web of Science ®Google Scholar
• Iilis L., Patangia G. N., Cavanagh J. B. Boutons terminaux and tri-ortho-cresyl phosphate neurotoxicity. Exp. Neurol. 1966; 14: 160
   PubMed Web of Science ®Google Scholar
• Blakemore W. F., Cavanagh J. B. ‘Neuraxonal dystrophy’ occurring in an experimental ‘dying back’ process in the rat. Brain 1969; 92: 789
   PubMed Web of Science ®Google Scholar
• Davies D. R., Cavanagh J. B., unpublished observations
   Google Scholar
• Johnson M. K., Barnes J. M. Age and the sensitivity of chicks to the delayed neurotoxic effects on some organophosphorus compounds. Biochem. Pharmacol. 1970; 19: 3045
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., unpublished observations
   Google Scholar
• Hine C. H., Dunlap M. K., Rice E. G., Coursey M. M., Gross R. M., Anderson H. H. The neurotoxicity and anticholinesterase properties of some substituted phenyl phosphates. J. Pharmacol. Exp. Ther. 1956; 116: 227
   PubMed Web of Science ®Google Scholar
• Henschler D. Die trikresylphosphatvergiftung. Klin. Wochenschr. 1958; 36: 663
   PubMedGoogle Scholar
• Bondy H. F., Field E. J., Worden A. N., Hughes J. P. W. A study of the acute toxicity of the tri-aryl phosphates used as plasticisers. Br. J. Ind. Med. 1960; 17: 190
   PubMedGoogle Scholar
• Aldridge W. N., Barnes J. M. Neurotoxic and biochemical properties of some triaryl phosphates. Biochem. Pharmacol. 1961; 6: 177
   PubMed Web of Science ®Google Scholar
• Aldridge W. N. Tricresyl phosphates and cholinesterase. Biochem. J. 1954; 56: 185
   PubMed Web of Science ®Google Scholar
• Myers D. K., Rekel J. B. J., Veeger C., Kemp A., Simons E. G. L. Metabolism of triaryl phosphates in rodents. Nature (Lond) 1955; 176: 259
   PubMed Web of Science ®Google Scholar
• Casida J. E., Eto M., Baron R. L. Biological activity of a tri-o-cresyl phosphate metabolite. Nature (Lond.) 1961; 191: 1396
   PubMed Web of Science ®Google Scholar
• Eto M., Casida J. E., Eto E. Hydroxylation and cyclization reactions involved in the metabolism of tri-o-cresyl phosphate. Biochem. Pharmacol. 1962; 11: 337
   PubMed Web of Science ®Google Scholar
• Baron R. L., Bennett D. R., Casida J. E. Neurotoxic syndrome produced in chickens by a cyclic phosphate metabolite of tri-o-cresyl phosphate—a clinical and pathological study. Br. J. Pharmacol. 1962; 18: 465
   Web of Science ®Google Scholar
• Taylor J. D. A neurotoxic syndrome produced in cats by a cyclic phosphate metabolite of tri-o-cresyl phosphate. Toxicol Appl. Pharmacol. 1967; 11: 538
   PubMed Web of Science ®Google Scholar
• Baron R. L., Casida J. E. Enzymatic and antidotal studies on the neurotoxic effect of certain organophosphates. Biochem. Pharmacol. 1962; 11: 1129
   PubMed Web of Science ®Google Scholar
• Earl C. J., Thompson R. H. S. Cholinesterase levels in the nervous system in tri-ortho-cresyl phosphate poisoning. Br. J. Pharmacol. 1952; 7: 685
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., Davies D. R., Holland P., Lancaster M. Comparison of the functional effects of Dyflos, tri-o-cresyl phosphate and tri-p-ethyl-phenyl phosphate in chickens, ifr. J. Pharmacol. 1961; 17: 21
   Google Scholar
• Aldridge W. N., Barnes J. M. Further observations on the neurotoxicity of organophosphorus compounds. Biochem. Pharmacol. 1966; 15: 541
   PubMed Web of Science ®Google Scholar
• Johnson M. K. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. Biochem. J. 1969; 111: 487
   PubMed Web of Science ®Google Scholar
• Johnson M. K. Organophosphorus and other inhibitors of brain ‘neurotoxic esterase’ and the development of delayed neurotoxicity in hens. Biochem. J. 1970; 120: 523
   PubMed Web of Science ®Google Scholar
• Johnson M. K., personal communication
   Google Scholar
• Diezel P. B., Quadbeck G. Nervenschädigung durch p-bromphenylacetyl-harnstoff. Naunyn Schmiedeberg's Arch. Pharmakol. Exp. Pathol. 1960; 238: 534
   PubMedGoogle Scholar
• Toman J. E. P., Goodman L. S. Anticonvulsants. Physiol. Rev. 1948; 28: 409
   PubMed Web of Science ®Google Scholar
• Swinyard E. A., Brown W. C., Goodman L. S. Comparative assays of antiepileptogenic drugs in mice and rats. J. Pharmacol Exp. Ther. 1952; 106: 319
   PubMed Web of Science ®Google Scholar
• Everett G. M., Richards R. K. Pharmacological studies of phenylacetylurea (Phenurone), an anticonvulsant drug. J. Pharmacol Exp. Ther. 1952; 106: 303
   PubMed Web of Science ®Google Scholar
• Chen F. C-K., Cavanagh J. B. Factors affecting neurotoxicity byp-bromophenylacetylurea in rats. Br. J. Exp. Pathol. 1971; 52: 315
   PubMedGoogle Scholar
• Cavanagh J. B., Chen F. C-K., Kyu M. H., Ridley A. The experimental neuropathy in rats caused by p-bromophenylacetylurea. J. Neurol. Neurosurg. Psychiatry 1968; 31: 471
   PubMed Web of Science ®Google Scholar
• Zamora A. J., Chen F. C-K., Cavanagh J. B., unpublished findings
   Google Scholar
• Cavanagh J. B., Chen F. C-K. Amino acid incorporation into protein during the “silent phase” before organomercury andp -bromophenylacetylurea neuropathy in the rat. Acta Neuropathol. (Berl) 1971; 19: 216
   PubMed Web of Science ®Google Scholar
• Chen F. C-K., Cavanagh J. B., unpublished observations
   Google Scholar
• Pegum J. S. Nicotinic acid and burning feet. Lancet 1952; 2: 536
   Google Scholar
• Jones W. A., Jones G. P. Peripheral neuropathy due to isoniazid. Lancet 1953; 1: 1073
   PubMedGoogle Scholar
• Gammon G. D., Burge F. W., King G. Neural toxicity in tuberculous patients treated with isoniazid (iso -nicotinic acid hydrazide). Arch. Neurol. Psychiatr. (Chicago) 1953; 70: 64
   PubMedGoogle Scholar
• Biehl J. P., Skavlem J. H. Toxicity of isoniazid. Am. Rev. Tuberc. 1953; 68: 296
   PubMedGoogle Scholar
• Evans D. A. P., Manley K. A., McKusick V. A. Genetic control of isoniazid metabolism in man. Br. Med. J. 1960; 2: 485
   PubMed Web of Science ®Google Scholar
• Harris H. W., Knight R. A., Selin M. J. Comparison of isoniazid concentrations in the blood of people of Japanese and European descent. Am. Rev. Tuberc 1958; 78: 944
   PubMedGoogle Scholar
• Boone I. U., Woodward K. T. Relationships of pyridoxine and its derivatives to the mechanism of action of isoniazid. Proc. Soc. Exp. Biol. Med. 1953; 84: 292
   PubMed Web of Science ®Google Scholar
• Biehl J. P., Vilter R. W. Effect of isoniazid on vitamin B6 metabolism, its possible significance in producing isoniazid neuritis. Proc. Soc. Exp. Biol. Med. 1954; 85: 389
   PubMed Web of Science ®Google Scholar
• Zbinden G., Studer A. Experimenteller beitrage zur frage der isoniazid-neuritis ihrer beeinflussung durch pyridoxin. Z. Tuberk. Erkr. Thoraxorgane 1955; 107: 97
   Google Scholar
• Zbinden G., Studer A. Zur wirkung von vitaminen der B-gruppe auf die experimentelle isoniazid-neuritis. Schweiz. Z. Allg. Pathol. Bakteriol. 1955; 18: 1198
   PubMedGoogle Scholar
• Klinghardt G. W. Experimentelle degenerative nervenschadigungen durch verbindungen des hydrazins und hydroxylamins. Naturwissenschaften 1961; 48: 381
   Google Scholar
• Cavanagh J. B. On the pattern of change in peripheral nerves produced by isoniazid intoxication in rats. J. Neurol. Neurosurg. Psychiatry 1967; 30: 26
   Web of Science ®Google Scholar
• Schlaepfer W. W., Hager H. Ultrastructural studies of INH-induced neuropathy in rats. I. Early axonal changes. Am. J. Pathol. 1964; 45: 209
   PubMed Web of Science ®Google Scholar
• Schlaepfer W. W., Hager H. Ultrastructural studies of INH-induced neuropathy in rats. II. Alteration and decomposition of the myelin sheaths. Am. J. Pathol. 1964; 45: 423
   PubMed Web of Science ®Google Scholar
• Smith B. The myenteric plexus in drug-induced neuropathy. J. Neurol. Neurosurg. Psychiatry 1967; 30: 506
   PubMed Web of Science ®Google Scholar
• Metzler D. E., Ikawa M., Snell E. E. A general mechanism for vitamin B6—catalysed reactions. J. Am. Chem. Soc. 1954; 76: 648
   Web of Science ®Google Scholar
• McCormick D. B., Snell E. E. Pyridoxal kinase of human brain and its inhibition by hydrazine derivatives. Proc. Natl. Acad. Sci. U.S.A. 1959; 45: 1371
   PubMed Web of Science ®Google Scholar
• McCormick D. B., Snell E. E. Comparative inhibition of pyridoxal kinase and glutamic acid decarboxylase by carbonyl reagents. Proc. Soc. Exp. Biol. Med. 1960; 104: 554
   Web of Science ®Google Scholar
• McCormick D. B., Snell E. E. Pyridoxal phospho-kinases. II. Effects of inhibitors. J. Biol. Chem. 1961; 236: 2085
   PubMed Web of Science ®Google Scholar
• Holtz P., Palm D. Pharmacological aspects of vitamin B6. Pharmacol. Rev. 1964; 16: 113
   PubMed Web of Science ®Google Scholar
• Tower D. B. Neurochemical aspects of pyridoxine metabolism and function. Am. J. Clin. Nutr. 1956; 4: 329
   PubMed Web of Science ®Google Scholar
• Killam K. F., Bain J. A. Convulsant hydrazides. I.In vitro andin vivo inhibition of vitamin B6 enzymes by convulsant hydrazides. J. Pharmacol. Exp. Ther. 1957; 119: 255
   PubMed Web of Science ®Google Scholar
• Sauberlich H. E. Human requirements for vitamin B6. Vitam. Horn. 1964; 22: 807
   PubMed Web of Science ®Google Scholar
• Palmer A. C., Noel P. R. B. Neuropathological effects of dosing dogs with isonicotinic hydrazide, and with its methanesulphonate derivative. Nature (Lond.) 1965; 205: 506
   PubMed Web of Science ®Google Scholar
• Carlton W. W., Kreutzberg G. Isonicotinic acid-hydrazide—induced spongy degeneration of the white matter in the brains of Pekin ducks. Am. J. Pathol. 1966; 48: 91
   PubMed Web of Science ®Google Scholar
• Carlton W. W. Neural toxicity of isonicotinic acid hydrazide (isoniazid) for chickens. Avian Dis. 1967; 11: 241
   PubMed Web of Science ®Google Scholar
• Coursin D. B. The present status of vitamin B6 metabolism. Am. J. Clin. Nutr. 1961; 9: 414
   PubMedGoogle Scholar
• Munck B. G. Amino acid transport by the small intestine of the rat. Biochim. Biophys. Acta 1965; 94: 136
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., Chen F. C-K., unpublished observations
   Google Scholar
• Wilson J. E., Vigneaud V. L-Penicillamine as a metabolic antagonist. Science 1948; 107: 653
   PubMed Web of Science ®Google Scholar
• Kirkendahl W. M., Page E. B. Polyneuritis occurring during hydralazine therapy. J.A.M.A. 1958; 167: 427
   PubMed Web of Science ®Google Scholar
• Poole G. W., Schneeweiss J. Peripheral neuropathy due to ethionamide. Am. Rev. Resp. Dis. 1961; 84: 890
   PubMedGoogle Scholar
• Cavanagh J. B., Mellick R. S. On the nature of the peripheral nerve lesions associated with acute intermittent porphyiia. J. Neurol. Neurosurg. Psychiatry 1965; 28: 320
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., Ridley A. The nature of the neuropathy complicating acute intermittent porphyria. Lancet 1967; 2: 1023
   PubMed Web of Science ®Google Scholar
• Ridley A. The neuropathy of acute intermittent porphyria. Q. J. Med. 1969; 38: 307
   PubMedGoogle Scholar
• Mason V. R., Courville C., Ziskind E. The porphyrins in human disease. Medicine 1933; 12: 355
   Google Scholar
• Denny-Brown D., Sciarra D. Changes in the nervous system in acute porphyria. Brain 1945; 68: 1
   Web of Science ®Google Scholar
• Hierons R. Changes in the nervous system in acute porphyria. Brain 1957; 80: 176
   PubMed Web of Science ®Google Scholar
• Ridley A., Hierons R., Cavanagh J. B. Tachycardia and the neuropathy of porphyria. Lancet 1968; 2: 708
   PubMed Web of Science ®Google Scholar
• Kezdi P. Neurogenic hypertension in man in porphyria. Arch. Intern. Med. 1954; 94: 122
   Google Scholar
• Rimington C. Haems and porphyrins in health and disease. Acta Med. Scand. 1952; 143: 161
   PubMedGoogle Scholar
• De Matteis F., Rimington C. The biochemical disturbance in acute intermittent porphyria. Lancet 1962; 1: 1332
   PubMed Web of Science ®Google Scholar
• De Matteis F. Disturbances of liver porphynn metabolism caused by drugs. Pharmacol. Rev. 1967; 19: 523
   PubMed Web of Science ®Google Scholar
• Asbury A. K., Sidman R. L., Wolf M. K. Drug induced porphynn accumulation in the nervous system. Neurology (Minneap.) 1966; 16: 320
   Web of Science ®Google Scholar
• Price J. M., Brown R. R., Peters H. A. Tryptophan metabolism in porphyria. schizophrenia, and a variety of neurological and psychiatric diseases. Neurology (Minneap.) 1959; 9: 456
   PubMed Web of Science ®Google Scholar
• Hamfelt A., Wetterberg L. Neuropathy in porphyria. Lancet 1968; 1: 50
   PubMed Web of Science ®Google Scholar
• Davidson M., Feinleib M. Carbon disulfide poisoning, a review. Am. Heart J. 1972; 83: 100
   PubMed Web of Science ®Google Scholar
• Tiller J. R., Schilling R. S. F., Morris J. N. Occupational toxic factor in mortality from coronary heart disease. Br. Med. J. 1968; 2: 407
   Google Scholar
• Hernberg S., Postanen T., Nordman C. H., Sumari P. Coronary heart disease among workers exposed to carbon disulphide. Br. J. Ind. Mod. 1970; 27: 313
   PubMedGoogle Scholar
• Lewey F. M. Neurological, medical and biochemical signs and symptoms indicating chronic industrial carbon disulfide absorption. Ann. Intern. Med. 1941; 15: 869
   Google Scholar
• Vigliani E. C. Carbon disulphide poisoning in viscose rayon factories. Br. J. Ind. Med. 1954; 11: 235
   PubMedGoogle Scholar
• Brieger H. Chronic carbon disulfide poisoning. J. Occup. Med. 1961; 3: 302
   Google Scholar
• Ferraro A., Jervis G., Flicker D. Neuropathological changes in experimental carbon disulfide poisoning in cats. Arch. Pathol. 1941; 32: 723
   Google Scholar
• Richter R. Degeneration of the basal ganglia in monkeys from chronic carbon disulfide poisoning. J. Neuropathol. Exp. Neurol. 1945; 4: 324
   PubMed Web of Science ®Google Scholar
• Cohen A. E., Scheel L. D., Kopp J. F., Stockwell F. R., Keenan R. G., Mountain J. T., Paulus H. J. Biochemical mechanisms in chronic carbon disulfide poisoning. Am. Ind. Hyg. Assoc. J. 1959; 20: 303
   PubMedGoogle Scholar
• Alpers B. J., Lewey F. H. Changes in the nervous system following carbon disulfide poisoning in animals and man. Arch. Neurol. Psychiatr. 1940; 44: 725
   Google Scholar
• Gordy S. T., Trumper M. Carbon disulfide poisoning. Report of 21 cases. Ind. Med. 1940; 9: 231
   Google Scholar
• Lewey F. H. Experimental chronic carbon disulfide poisoning in dogs. J. Ind. Hyg. 1941; 23: 415
   Google Scholar
• Eldjarn L. Metabolism of tetraethyl thiuramdisulphide (antabuse. aversan) in the rat, investigated by means of radioactive sulphur. Scand. J. Clin. Lab. Invest. 1950; 2: 198
   PubMed Web of Science ®Google Scholar
• Eldjarn L. Metabolism of tetraethyl thiuramdisulphide in man. investigated by means of radioactive sulphur. Scand. J. Clin. Lab. Invest. 1950; 2: 202
   PubMed Web of Science ®Google Scholar
• Stromme J. H. Metabolism of disulfiram and diethyl dithiocarbamate in rats with demonstration of anin vivo ethanol-induccd inhibition of the glucuronic acid conjugation of the thiol. Biochem. Pharmacol. 1965; 14: 353
   PubMedGoogle Scholar
• Kane F. J. Carbon disulfide intoxication from overdosage of disulfiram. Am. J. Psychiatry 1970; 127: 690
   PubMed Web of Science ®Google Scholar
• Gardner-Thorpe C., Benjamin S. Peripheral neuropathy alter disulfiram administration. J. Neurol. Ncurosurg. Psychiatry 1971; 34: 253
   PubMed Web of Science ®Google Scholar
• Anon. Peripheral neuropathy and disulfiram. Lancet 1971; 2: 649
   Web of Science ®Google Scholar
• Melson F., Weigelt H. The influence of tetramethyl thiuram and carbon disulphide on the enzymes monoamine oxidase and alcohol dehydrogenase. Toxicology of Carbon Disulphide, H. Brieger, J. Teisinger. Excerpta Medica foundation. Elsevier, Amsterdam 1967; 100
   Google Scholar
• McHowell J. C., Edington N. The neurotoxicity of sodium diethyldithiocarbamate in the hen. J. Neuropathol. Exp. Neurol. 1968; 27: 464
   Web of Science ®Google Scholar
• Edington N., McHowell J. C. The neurotoxicity of sodium diethyldithiocarbamate in the rabbit. Acta Neuropathol. (Berl) 1969; 12: 339
   PubMed Web of Science ®Google Scholar
• Rasul A. R., McHowell J. C. A comparison of the effect of sodium diethyldithiocarbamate on the central nervous system of young and domestic adult fowl. Acta Neuropathol. (Berl) 1973; 24: 68
   PubMed Web of Science ®Google Scholar
• Rasul A. R., McHowell J. C. Further observations on the response of the peripheral and central nervous system of the rabbit to sodium diethyldithiocarbamate. Acta Neuropathol. (Berl) 1973; 24: 161
   PubMed Web of Science ®Google Scholar
• Sunderman F. W., Sunderman F. W., Jr. Dithiocarb. A new therapeutic agent for persons exposed to nickel carbonyl. Am. J. Med. Sci. 1958; 236: 26
   PubMed Web of Science ®Google Scholar
• Sunderman F. W., White J. C., Sunderman F. W., Jr. Dithiocarbamates in the treatment of Wilson's disease. Am. J. Med. 1963; 34: 875
   PubMedGoogle Scholar
• Sunderman F. W. Diethyldithiocarbamate therapy of thallotoxicosis. Am. J. Med. Sci. 1967; 253: 209
   Web of Science ®Google Scholar
• Kamerbeek A., Rauws A. G., ten Ham M. G., Van Heijst A. N. P. Dangerous redistribution of thallium by treatment with sodium diethyldithiocarbamate. Acta Med. Scand. 1971; 189: 149
   PubMed Web of Science ®Google Scholar
• Van Steenis G., Van Logten M. J. Neurotoxic effect of the dithiocarbamatetectoram on the chick embryo. Toxicol Appl. Pharmacol. 1971; 19: 675
   PubMed Web of Science ®Google Scholar
• McKee R., Kiper C., Fountain J. H., Riskin A. M., Drinker P. A solvent vapour carbon disulfide -absorption, elimination metabolism and mode of action. J.A.M.A. 1943; 122: 217
   Google Scholar
• Thorne G. D., Ludwig R. A. The Dithiocarbamates and Related Compounds. Excerpta Medica Foundation, Elsevier, Amsterdam 1962
   Google Scholar
• Scheel L. D. Experimental carbon disulfide poisoning in rabbits, its mechanism and similarities with human case reports. Toxicology of Carbon Disulphide, H. Brieger, K. Teisinger. Excerpta Medica Foundation, Elsevier, Amsterdam 1967; 107
   Google Scholar
• Edington N., McHowell J. C. Changes in the nervous system of rabbits following the administration of sodium diethyldithiocarbamate. Nature (Lond.) 1966; 210: 1060
   PubMed Web of Science ®Google Scholar
• Vašák V., Kopecky J. On the role of pyridoxamine in the mechanism of the toxic action of carbon disulphide. Toxicology of Carbon Disulphide, H. Brieger, J. Teisinger. Excerpta Medica Foundation, Elsevier, Amsterdam 1967; 35
   Google Scholar
• Abramova J. I. The questions of pathogenesis, specific prevention and therapy of carbon disulphide intoxication. Toxicology of Carbon Disulphide, H. Brieger, J. Teisinger. Excerpta Medica Foundation, Elsevier, Amsterdam 1967; 32
   Google Scholar
• Magos L. The effects of carbon disulphide exposure on brain catecholamines in rats. Br. J. Pharmacol 1970; 39: 26
   PubMed Web of Science ®Google Scholar
• Magos L., Jervis J. A. E. Effects of diethyldithiocarbamate and carbon disulphide on brain tyrosine. J. Pharm. Pharmacol. 1970; 22: 936
   PubMed Web of Science ®Google Scholar
• Tarkowski S., Ctemer J. E. Metabolism of glucose and free amino acids in brain, studied with14 C-labelled glucose and butyrate in rats intoxicated with carbon disulphide. J. Neurochem. 1972; 19: 2631
   PubMed Web of Science ®Google Scholar
• Chamberlain W. P., Bloombergh H. D., Kilbourne E. D. A study of the influence of rice diet and of inanition on the production of multiple neuritis of fowls and the bearing thereof on the aetiology of beri-beri. Philipp. J. Sci. 1911; 6: 177
   Google Scholar
• Vedder E. B., Clark E. A study of polyneuritis gallinarum. Philipp. J. Sci. 1912; 7: 423
   Google Scholar
• Swank R. L., Prados M. Avian thiamine deficiency. Arch. Neurol. Psychiatr. 1942; 47: 97
   Google Scholar
• Swank R. L. Avian thiamine deficiency, correlation of pathology and clinical behaviour. J. Exp. Med. 1940; 71: 683
   PubMedGoogle Scholar
• Follis R. H. Pathology of Nutritional Disease. Charles C Thomas, Springfield, Ill 1948
   Google Scholar
• Stevenson M. J. The effects of a thiamine analogue on the histopathology of rat tissues. Am. J. Vet. Res. 1950; 11: 105
   Web of Science ®Google Scholar
• Eaton Laboratories. The nitrofurans. Introduction to the Nitrofurans. Norwich, N.Y. 1958; Vol. 1
   Google Scholar
• Collings H. Polyneuropathy associated with nitrofuran therapy. Arch. Neurol 1960; 3: 656
   PubMedGoogle Scholar
• Ellis F. G. Acute polyneuritis after nitrofurantoin therapy. Lancet 1962; 2: 1136
   Web of Science ®Google Scholar
• Robertson D. H. H. Nitrofurazone. T. rhodesiense sleeping sickness. 1959; 41, Report of the East African Trypanosome Research Organization
   Google Scholar
• Paul M. F., Paul G. E., Kopko F., Bryson M. J., Harrington C. Inhibition by furacin of citrate formation in testis preparations. J. Biol. Chem. 1954; 206: 491
   PubMed Web of Science ®Google Scholar
• Loughridge L. W. Peripheral neuropathy due to nitrofurantoin. Lancet 1962; 2: 1133
   Web of Science ®Google Scholar
• Behar A., Rachmilewitz E., Rahamimoff R., Demau M. Experimental nitrofurantoin neuropathy in rats. Arch. Neurol. 1965; 13: 160
   PubMedGoogle Scholar
• Robertson D. H. H., Knight R. H. Observations on the polyneuropathy and disordered pyruvate metabolism induced by nitrofurazone in cases of sleeping sickness due to T. rhodesiense. Acta Trop. (Basel) 1964; 21: 239
   Google Scholar
• Hassin G. B. Symptomatology of arsenical polyneuritis. J. Nerv. Ment. Dis. 1930; 72: 628
   Google Scholar
• Gringschgl G. Demonstration vier fälle von Arsenikvergiftung in einer Familie. Wien. Med. Wochenschr. 1956; 10: 248
   Google Scholar
• Harding J. D. J., Lewis G., Done J. T. Experimental arsenilic acid poisoning in pigs. Vet. Rec. 1968; 83: 560
   PubMed Web of Science ®Google Scholar
• Joiner C. L., McArdle B., Thompson R. H. S. Blood pyruvate estimations in the diagnosis and treatment of polyneuritis. Brain 1950; 73: 431
   PubMed Web of Science ®Google Scholar
• Tucker A. The Toxic Metals. Pan-Ballantine, London 1972
   Google Scholar
• McAlpine D., Araki S. Minamata Disease. An unusual neurological disorder caused by contaminated fish. Lancet 1958; 2: 629
   PubMed Web of Science ®Google Scholar
• McAlpine D., Araki S. Minamata disease. Arch. Neurol. 1959; 1: 522
   Google Scholar
• Hunter D., Bomford R. R., Russell D. S. Poisoning by methyl-mercury compounds. Q. J. Med., N.S. 1940; 9: 193
   Google Scholar
• Hunter D., Russell D. S. Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds. J. Neurol. Neurosurg. Psychiatry 1954; 17: 235
   PubMed Web of Science ®Google Scholar
• Kurland L. F., Faro S. N., Siedler H. Minamata disease. World Neurol. 1960; 1: 370
   PubMedGoogle Scholar
• Takeuchi T., Morikawa N., Matsumato H., Shiraishi Y. A pathological study of Minamata disease in Japan. Acta Neuropathol. (Berl.) 1962; 2: 40
   Google Scholar
• Bakir F., Damluji S. F., Amin-Zaki L., Murtadha M., Khalidi A., Al-Rawi N. Y., Tikriti S., Dhahir H. I., Qarkson T. W., Smith J. C., Doherty R. A. Methyl-mercury poisoning. Iraq Sci. 1973; 181: 230
   Google Scholar
• Okinaka, et al. Encephalopathy due to an organic mercury compound. Neurology (Minneap.) 1964; 14: 69
   PubMed Web of Science ®Google Scholar
• Matsumoto H., Koya G., Takeuchi T. Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J. Neuropathol. Exp. Neurol. 1965; 24: 563
   PubMed Web of Science ®Google Scholar
• Miyakawa T., Deshimaru M. Electron microscopic study of experimentally induced poisoning due to organic mercury compound. Acta Neuropathol. (Berl.) 1969; 14: 126
   PubMed Web of Science ®Google Scholar
• Miyakawa T., Deshimaru M., Sumiyoshi S., Teraoka A., Udo N., Haltori E., Tatetsu S. Experimental organic mercury poisoning—pathological changes in peripheral nerves. Acta Neuropathol. (Berl.) 1970; 15: 45
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., Chen F. C-K. The effects of methyl-mercury dicyandiamide on the peripheral nerves and spinal cord of rats. Acta Neuropathol. (BerL) 1971; 19: 208
   PubMed Web of Science ®Google Scholar
• Chang L. W., Hartmann H. A. Ultrastructural studies of the nervous system after methyl mercury. Acta Neuropathol. (BerL) 1972; 20: 122
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., Jacobs J. M. 1973, unpublished observations
   Google Scholar
• Chang L. W., Desnoyers P. A., Hartmann H. A. Quantitative cytochemical studies of RNA in experimental mercury poisoning. I. Changes in RNA content. J. Neuropathol. Exp. Neurol. 1972; 31: 489
   PubMed Web of Science ®Google Scholar
• Berglund F., et al. Report from an expert group. Methyl mercury in fish. A toxicologic-epidemiologic evaluation of the risks. Nord. Hyg. Tidskr. 1971, Suppl., 4
   Google Scholar
• Norseth T., Qarkson F. W. Studies on the biotransformation of2 0 3 Hg-labelled methyl-mercury chloride in rats. Arch. Environ. Health 1970; 21: 717
   PubMed Web of Science ®Google Scholar
• Swensson A. Investigation on the toxicity of some organic mercury compounds which are used as seed disinfectants. Acta Med. Scand. 1954; 143: 365
   Google Scholar
• Brown I. H. Chronic mercurialism. A cause of the clinical syndrome of amyotrophic lateral sclerosis. Arch. Neurol. Psychiatr. 1954; 72: 674
   PubMedGoogle Scholar
• Hunter D. Diseases of Occupations. English University Press, London 1969
   Google Scholar
• Noetzel H. Schädigung und verkalkung der Kornerschicht des Kleinhirns bei chronischer experimenteller Sublimatvergiftung. Beitr. Pathol. Anat. 1955; 226: 115
   Google Scholar
• Paterson D., Greenfield J. G. Erythroedema polyneuritis (the so-called Pink Disease). Q. J. Med. 1923; 17: 6–24
   Google Scholar
• Wyllie W. G., Stern R. O. Pink Disease. Its morbid anatomy with a note on treatment. Arch. Dis. Child. 1931; 6: 137
   PubMedGoogle Scholar
• Warkany J., Hubbard D. M. Mercury in the urine of children with acrodynia. Lancet 1948; 1: 829
   PubMed Web of Science ®Google Scholar
• Colver T. Pink disease and mercury in Sheffield, 1947–55. Br. Med. J. 1956; 1: 897
   PubMedGoogle Scholar
• Annotation. Teething powders. Lancet 1953; 2: 1247, 1321
   Google Scholar
• Gritzka T. L., Trump B. F. Renal tubular lesions caused by mercuric chloride. Am. J. Pathol. 1968; 52: 1225
   PubMed Web of Science ®Google Scholar
• Mustakallio K. K., Telkkä A. Histochemical localization of the mercurial inhibition of succininc dehydrogenase in rat kidney. Science 1953; 118: 320
   PubMed Web of Science ®Google Scholar
• Telkkä A., Mustakallio K. K. Proximal and distal mercurial inhibition of succinic dehydrogenase in kidney tubules of rat. Science 1955; 121: 146
   PubMed Web of Science ®Google Scholar
• Bergstrand A., Friberg L., Odeblad E. Localization of mercury in kidneys after subcutaneous administration. Arch. Ind. Health 1958; 17: 253
   PubMedGoogle Scholar
• Fiiberg L. Studies on the accumulation, metabolism and excretion of inorganic mercury (Hg203) after prolonged subcutaneous administration to rats. Acta Pharmacol. Toxicol. (Kbh.) 1956; 12: 411
   PubMedGoogle Scholar
• Magos L. Mercury-blood interactions and mercury uptake by the brain after vapor exposure. Environ. Res. 1967; 1: 322
   Google Scholar
• Magos L., Butler W. H. Cumulative effects of methyl-mercury dicyandiamide given orally to rats. Food Cosmet. Toxicol. 1972; 10: 513
   PubMedGoogle Scholar
• Magos L., Cavanagh J. B. 1973, unpublished observations
   Google Scholar
• Yoshino Y., Mozai T., Nakao K. Biochemical changes in rat brain poisoned with an alkyl mercury compound with special reference to the inhibition of protein synthesis in brain cortex slices. J. Neurochem. 1966; 13: 1223
   PubMed Web of Science ®Google Scholar
• Cavanagh J. B., Chen F. C-K. Amino acid incorporation in protein during the ‘silent phase’ before organomercury andp -bromophenylacetylurea neuropathy in the rat. Acta Neuropathol. (Berl.) 1971; 19: 216
   PubMed Web of Science ®Google Scholar
• Leek J. M., Millar E. L. M. Incidence of malformations since the introduction of thalidomide. Br. Med. J. 1962; 2: 16
   PubMedGoogle Scholar
• Florence A. L. Is thalidomide to blame?. Br. Med. J. 1960; 2: 1954
   Google Scholar
• Fullerton P. M., Kremer M. Neuropathy after intake of thalidomide (distaval). Br. Med. J. 1961; 2: 855
   PubMed Web of Science ®Google Scholar
• Hafström T. Polyneuritis after neurosedyn (thalidomide), and its prognosis. Acta Neurol. Scand. 1967; 43(Suppl. 32)1
   PubMedGoogle Scholar
• Gebbels E. Die Thalidomid-Polyneuritis. Geo. Thieme Verlag, Stuttgart 1968
   Google Scholar
• Fullerton P. M., O'Sullivan D. J. Thalidomide neuropathy: a clinical, electrophysiological and histological follow-up study. J. Neurol. Neurosurg. Psychiatry 1968; 31: 543
   PubMed Web of Science ®Google Scholar
• Klinghaidt G. W. 1965, quoted by Fullerton, P. M. and O'Sullivan, D. J., Thalidomide neuropathy: a clinical, electrophysiological and histological follow-up study. J. Neurol. Neurosurg. Psychiatry 1968; 31: 543
   PubMed Web of Science ®Google Scholar
• Staemmler M., Lagler F. Tierexperimenteller untersuchungen zur Frage Thalidomid und Nervenschadigungen. Arzneim. Forsch. 1965; 15: 504
   PubMedGoogle Scholar
• Diezel P. B. Morphologische veränderungen bei experimenteller Thalidomid-Neuropathic und thalidomidbedingten Extremitatenmissbildungen. Munch. Med. Wochenschr. 1963; 105: 2265
   Google Scholar
• McColl J. D., Globus M., Robinson S. An attempted reversal of thalidomide embryopathy in the rat by glutamine. Can. J. Physiol. Pharmacol. 1965; 43: 69
   PubMed Web of Science ®Google Scholar
• Schumacher H., Smith R. L., Williams R. T. The metabolism of thalidomide. The spontaneous hydrolysis of thalidomide in solution. Br. J. Pharmacol. 1965; 25: 304
   Google Scholar
• Schumacher H., Smith R. L., Williams R. T. The metabolsim of thalidomide. The fate of thalidomide and some of its hydrolysis products in various species. Br. J. Pharmacol. 1965; 25: 338
   PubMed Web of Science ®Google Scholar
• Fabro S., Schumacher H., Smith R. L., Stagg B. L., Williams R. T. The metabolism of thalidomide. Some biological effects of thalidomide and its metabolites. Br. J. Pharmacol. 1965; 25: 352
   Web of Science ®Google Scholar
• Gillette J. R. Acylation as a possible mechanism of thalidomide-induced teratogenicity. The Teratological Society 7th Annual Meeting, Estes Park, Colorado, 1967, Quoted by Becker, B. A., inDevelopmental Neurobiology, Himwich, W. A., Ed., Charles C Thomas, Springfield, Ill., 1970, 621.
   Google Scholar
• Fabro S., Smith R. L., Williams R. T. Thalidomide as a possible acylating agent. Nature (Lond) 1965; 208: 1208
   PubMed Web of Science ®Google Scholar
• Champy-Hatem S. Action de l'imidazole sur les premiers metabolites de la thalidomide. Arzneim. Forsch. 1965; 15: 508
   PubMedGoogle Scholar
• Gross P. R. RNA metabolism in embryonic development and differentiation. N. Engl. J. Med. 1967; 276: 1239
   PubMed Web of Science ®Google Scholar
• Zillig W., Krone W., Albers M. Untersuchungen Zur Biosynthese der Proteine. III. Beitrage zur Kenntnis der Zusammensetzung und struktur der Ribosomen. Z. Physiol. Chem. 1959; 317: 131
   PubMedGoogle Scholar
• Cohen S. S., Lichtenstein J. Polyamines and ribosome structure. J. Biol Chem. 1960; 235: 2112
   PubMed Web of Science ®Google Scholar
• Tissières A., Hopkins J. W. Factors affecting amino acid incorporation into proteins byEscherichia coli ribosomes. Proc. Natl. Acad. Sci. U.S.A. 1961; 47: 2015
   PubMed Web of Science ®Google Scholar
• Hirschberg E., Osnos M., Bryant S., Ultman S. E. Thalidomide. Effects on enzymes of glutamic acid metabolism in mice. Science 1964; 143: 1343
   Web of Science ®Google Scholar
• Lamy, Sur les effets toxique du thallium. J. Pharmac. Chim. 1863; 44: 285
   Google Scholar
• Munch J. C. Human thaliotoxicosis. J.A.M.A. 1934; 102: 1929
   Google Scholar
• Heyroth F. F. Thallium, a review and summary of the medical literature. U.S. Public Health Serv. Public Health Rep. 1947, Suppl.: 197
   Google Scholar
• Matthys R. Neuf observations d'empoisonnement Criminel par le thallium. Ann. Med. Lég. 1955; 35: 237
   Google Scholar
• Prick J. J. G., Smith W. G. S., Muller L. Thallium Poisoning. Elsevier, Amsterdam 1955
   Google Scholar
• Reed D., Crawley J., Faro S. N., Pieper S. J., Kurland L. T. Thaliotoxicosis. Acute manifestations and sequelae. J.A.M.A. 1963; 183: 510
   Google Scholar
• Zook B. C., Holzworth J., Thornton G. W. Thallium poisoning in cats. J. Am. Vet. Med. Assoc. 1968; 153: 285
   PubMed Web of Science ®Google Scholar
• Zook B. C., Gilmore C. E. Thallium poisoning in dogs. J. Am. Vet. Med. Assoc. 1967; 151: 204
   PubMedGoogle Scholar
• Council on Drugs. Thaliotoxicosis—a recurring problem. J.A.M.A. 1957; 165: 1566
   PubMed Web of Science ®Google Scholar
• Rogers J. H. Thallium poisoning in N. S. Wales. Aust. Police J. 1957; 11: 125
   Google Scholar
• Cavanagh J. B., Fuller N. H., Johnson H. M., Rudge P. The effects of thallium salts, with particular reference to the nervous system changes. A report of three cases. Q. J. Med. 1973, in press
   Google Scholar
• Thyresson N. Experimental investigations on thallium. Acta Derm. Venereal. (Stockh.) 1950; 30: 417
   PubMedGoogle Scholar
• Truhaut R. Recherche sur la Toxicologie de Thallium. Institut Nationale de Securité pour la Prévention des Accidents de Travail, Paris 1959
   Google Scholar
• Lund A. Distribution of thallium in the organism and its elimination. Acta Pharmacol Toxicol. (Kbh.) 1956; 12: 251
   PubMedGoogle Scholar
• Allsopp J. L. Thallium poisoning. Australas. Ann. Med. 1953; 2: 144
   PubMedGoogle Scholar
• Grunfeld O., Hinostroza G. Thallium poisoning. Arch. Intern. Med. 1964; 114: 132
   PubMed Web of Science ®Google Scholar
• Passarge C., Wiecke H. H. Thallium polyneuritis. Fortschr. Neurol. Psychiatr. 1965; 33: 477
   Web of Science ®Google Scholar
• Kamerbeek H. H., Rauws A. G., ten Ham M., Van Heijst A. N. P. Dangerous redistribution of thallium by treatment with sodium diethyldithiocarbamate. Acta Med. Scand. 1971; 189: 149
   PubMed Web of Science ®Google Scholar
• Banks W. J., Pleasure D. E., Suzuki K., Nigro M., Katz R. Thallium poisoning. Arch. Neurol. 1972; 26: 456
   PubMedGoogle Scholar
• Peterson E. L., Murray M. R. Patterns of peripheral demyelinationin vitro. Ann. N. Y. Acad. Sci. 1965; 122: 39
   PubMed Web of Science ®Google Scholar
• Spencer P. S., Peterson E. R., Ricardo Madrid A., Raine C. S. Effects of thallium salts on neuronal mitochondria in organotypic cord-ganglia-muscle combination cultures. J. Cell Biol. 1973, in press
   PubMed Web of Science ®Google Scholar
• Greving R., Gegel O. Pathologisch-anatomische Befunde am Nervensystem nach Experimenteller Thallium-veigiftung. Z. Gesamte Neurol. Psychiatr. 1929; 120: 805
   Google Scholar
• Scharrer E. Histopathologische Befunde in Zentralnervensystem bei Thallium Vergiftung. Z. Gesamte Neurol. Psychiatr. 1933; 145: 454
   Google Scholar
• Gettler A. O., Weiss L. Thallium poisoning. III. Clinical toxicology of thallium. Am. J. Clin. Pathol. 1943; 13: 422
   Google Scholar
• Moeschlin S. Klinik und Therapie der Vergiftungen. Geo. Thieme Verlag, Stuttgart 1952
   Google Scholar
• Kaeser H. E., Lambert E. H. Nerve function studies in experimental polyneuritis. Electroencephalogr. Clin. Neurophysiol. Suppl. 1962; 22: 29
   Google Scholar
• Herman M. M., Bensch K. G. Light and electronmicroscopic studies of acute and chronic thallium intoxication in rats. Toxicol. Appl. Pharmacol. 1967; 10: 199
   PubMed Web of Science ®Google Scholar
• Gehring P. J., Hammond P. B. Mechanism for the increase in thallium excretion during the administration of potassium. Pharmacology 1966; 8: 218
   Google Scholar
• Gehring P. J., Hammond P. B. The interrelationship between thallium and potassium in animals. J. Pharmacol. Exp. Ther. 1967; 155: 187
   PubMed Web of Science ®Google Scholar
• Britten J. S., Blank M. Thallium activation of the (Na+ + K+) -activated ATPase. Biochim. Biophys. Acta 1968; 159: 160
   PubMed Web of Science ®Google Scholar
• Rusnyak I., Györgi L., Ormai S., Millner T. On some potassium-like qualities of the thallium ion. Experientia 1968; 24: 809
   PubMedGoogle Scholar
• Inturrisi C. E. Thallium activation of K+ -activated phosphatases from beef brain. Biochim. Biophys. Acta 1969; 173: 567
   PubMed Web of Science ®Google Scholar
• Inturrisi C. E. Thallium-induced dephosphorylation of a phosphorylated intermediate of the (sodium + thallium)-activated ATPase. Biochim. Biophys. Acta 1969; 173: 630
   Google Scholar
• Flesch P. Inhibition of keratinizing structures by systemic drugs. Pharmacol. Rev. 1963; 15: 653
   PubMed Web of Science ®Google Scholar
• Lund A. The effect of various substances on the excretion and the toxicity of thallium in the rat. Acta Pharmacol. Toxicol. (Kbh.) 1956; 12: 260
   PubMedGoogle Scholar
• Papp J. P., Gay P. C., Dodson V. N., Pollard H. M. Potassium chloride treatment in thallotoxicosis. Ann. Intern. Med. 1969; 71: 119
   PubMed Web of Science ®Google Scholar
• McCollister D. D., Oyen F., Rowe V. K. Toxicology of acrylamide. Toxicol. Appl. Pharmacol. 1964; 6: 172
   Web of Science ®Google Scholar
• Auld R. B., Bedwell S. F. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Can. Med. Assoc. J. 1967; 96: 652
   PubMed Web of Science ®Google Scholar
• Garland T. O., Patterson W. H. Six cases of acrylamide poisoning. Br. Med. J. 1967; 4: 134
   PubMed Web of Science ®Google Scholar
• Kupperman S. S. Effects of acrylamide on the nervous system of the cat. J. Pharmacol. Exp. Ther. 1958; 123: 180
   PubMed Web of Science ®Google Scholar
• Leswing R. J., Ribelin W. E. Physiologic and pathologic changes in acrilamide neuropathy. Arch. Environ. Health 1969; 18: 22
   Web of Science ®Google Scholar
• Fullerton P. M., Barnes J. M. Peripheral neuropathy in rats produced by acrylamide. Br. J. Ind. Med. 1966; 23: 210
   PubMedGoogle Scholar
• Hopkins A. The effect of acrylamide on the peripheral nervous system of the baboon. J. Neurol. Neurosurg. Psychiatry 1970; 33: 805
   PubMed Web of Science ®Google Scholar
• Hopkins A., Gilliatt R. W. Motor and sensory nerve conduction velocity in the baboon: normal values and changes during acrylamide neuropathy. J. Neurol. Neurosurg. Psychiatry 1971; 34: 415
   PubMed Web of Science ®Google Scholar
• Princeas J. The pathogenesis of dying back polyneuropathies. Part II. An ultrastructural study of experimental acrylamide intoxication in the rat. J. Neuropathol. Exp. Neurol. 1969; 28: 598
   PubMed Web of Science ®Google Scholar
• Pleasure D., Engel W. K. Axonal flow in experimental neuropathies. J. Neuropathol. Exp. Neurol. 1970; 29: 140
   Web of Science ®Google Scholar
• Hashimoto K., Ando K. Alterations of amino acid incorporation into proteins of the nervous systemin vitro after administration of acrylamide to rats. Biochem. Pharmacol. 1973; 22: 1057
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Aldridge W. N. Biochemical studies on acrylamide. A neurotoxic agent. Biochem. Pharmacol. 1970; 19: 259
   Google Scholar
• Neuss N., Gorman M., Boaz H. E., Cone N. J. Vinca alkaloids. X. Structure of leurocristine (LCR) and vincaleukoblastine (VLB). J. Am. Chem. Soc. 1962; 84: 1508
   Google Scholar
• Moress G. R., D'Agostino A. N., Jardio L. W. The neuropathy in lymphoblastic leukemia treated with vincristine. Arch. Neurol. 1967; 16: 377
   PubMedGoogle Scholar
• Gottschalk P. G., Dyck P. J., Kiely J. M. Vinca alkaloid neuropathy: nerve biopsy studies in rats and man. Neurology (Minneap.) 1968; 11: 875
   Google Scholar
• Shelanski M. L., Wiśniewski H. Neurofibrillary degeneration induced by vincristine neuropathy. Arch. Neurol. 1969; 20: 199
   PubMed Web of Science ®Google Scholar
• Bradley W. G., Lassman L. P., Pearce G. W., Walton J. N. The neuromyopathy of vincristine in man: clinical, electrophysiological and pathological studies. J. Neurol Sci. 1970; 10: 107
   PubMed Web of Science ®Google Scholar
• Uy Q. L., Moen T. H. Vincristine neurotoxicity in rodents. Johns Hopkins Med. J. 1967; 121: 349
   PubMedGoogle Scholar
• Slotwiner P., Song S. K., Anderson P. J. Spheromembraneous degeneration of muscle induced by vincristine. Arch. Neurol. 1966; 15: 172
   PubMed Web of Science ®Google Scholar
• Bradley W. G. The neuropathy of vincristine in the guinea pig. An electrophysiological and pathological study. J. Neurol. Sci. 1970; 10: 133
   PubMed Web of Science ®Google Scholar
• Prineas J. Tri-ortho -cresyl phosphate myopathy. Arch. Neurol. 1969; 21: 150
   PubMedGoogle Scholar
• Robbins E., Gonotas N. K. Histochemical and ultrastructural studies on HeLa cultures exposed to spindle inhibitors with special reference to the interphase cell. J. Histochem. Cytochem. 1964; 12: 704
   PubMed Web of Science ®Google Scholar
• Behnke O. Microtubules in disk-shaped blood cells. Int. Rev. Exp. Pathol. 1970; 91: 1
   Google Scholar
• Porter K. R. Cytoplasmic microtubules and their functions. Principles of Biomolecular Organisation, G. E. W. Wolstenholme, M. O'Connor. J. & A. Churchill, London 1966; 308
   Google Scholar
• Behnke O., Forer A. Evidence for four classes of microtubules in individual cells. J. Cell Sci. 1967; 21: 169
   Google Scholar
• James K. A. C., Bray J. J., Morgan I. G., Austin L. The effect of colchicine on the transport of axonal protein in the chicken. Biochem. J. 1970; 117: 767
   PubMed Web of Science ®Google Scholar
• Fernandez H. L., Huneeus F. C., Davison P. F. Studies on the mechanism of axoplasmic transport in the crayfish cord. J. Neurobiol. 1970; 1: 395
   PubMedGoogle Scholar
• Borisy G. G., Taylor E. W. The mechanism of action of colchicine. Colchicine binding to sea urchin eggs and their mitotic apparatus. J. Cell Biol. 1967; 34: 535
   PubMed Web of Science ®Google Scholar
• Borisy G. G., Taylor E. W. The mechanism of action of colchicine. Binding of colchicine-3 H to cellular protein. J. Cell Biol. 1967; 34: 525
   PubMed Web of Science ®Google Scholar
• Wiśniewski H., Terry R. D., Hirano A. Neurofibrillary pathology. J. Neuropathol. Exp. Neurol., 29: 163
   Google Scholar
• Cavanagh J. B., Blakemore W. F., Kyu M. H. Fibrillary accumulations in oligodendrocytle processes of rats subjected to portocaval anastomosis. J. Neurol. Sci. 1971; 14: 143
   PubMed Web of Science ®Google Scholar
• Mottet N. K., Hammar S. P. Ribosome crystals in necrotizing cells from the posterior necrotic zone of the developing chick limb. J. Cell Sci. 1972; 11: 403
   PubMed Web of Science ®Google Scholar
• Jacobs J. M., Cavanagh J. B. Aggregations of filaments in Schwann cells of spinal roots of the normal rat. J. Neurocytol. 1972; 1: 161
   PubMedGoogle Scholar
• Wisniewski H., Terry R. D. Experimental colchicine encephalopathy. I. Induction of neurofibrillary degeneration. Lab. Invest. 1967; 17: 577
   PubMed Web of Science ®Google Scholar
• Cline M. J. Effect of vincristine on synthesis of ribonucleic acid and protein in leukaemic leucocytes. Br. J. Haematol. 1968; 14: 21
   PubMed Web of Science ®Google Scholar
• Creasey W. A., Markiw M. E. Biochemical effects of vinca alkaloids. II. A comparison of the effects of colchicine, vinblastine and vincristine on the synthesis of ribonucleic acids in Ehrlich ascites carcinoma cells. Biochim. Biophys. Acta 1964; 87: 601
   PubMed Web of Science ®Google Scholar
• Agustin B. M., Creasey W. A. Vinca alkaloids and the synthesis of RNA in mouse brain. Nature (Lond.) 1967; 215: 965
   PubMed Web of Science ®Google Scholar
• Tsubaki T., Honma Y., Hoshi M. Neurological syndrome associated with clioquinol. Lancet 1971; 1: 696
   PubMed Web of Science ®Google Scholar
• Annotation. Only in Japan. Lancet 1971; 1: 690
   Web of Science ®Google Scholar
• Nakae K., Yamamoto S-I., Shigematsu I., Kono R. Relation between subacute myelo-optico-neuropathy (S.M.O.N.) and clioquinol. Nationwide survey. Lancet 1973; 1: 171
   PubMed Web of Science ®Google Scholar
• Marsden P. D., Knight R. Halogenated oxyquinoline derivatives. Lancet 1971; 1: 854
   PubMed Web of Science ®Google Scholar
• Inoue Y. K., Nishibe G., Nakamura Y. Virus associated with S.M.O.N. in Japan. Lancet 1971; 1: 853
   PubMed Web of Science ®Google Scholar
• Schmidt I. G., Schmidt L. H. Neurotoxicity of the 8-aminoquinolines. I. Lesions in the central nervous system of the rhesus monkey induced by administration of plasmocid. J. Neuropathol. Exp. Neurol. 1948; 7: 369
   Google Scholar
• Schmidt I. G., Schmidt L. H. Neurotoxicity of 8-aminoquinolines. II. Reactions of various experimental animals to plasmocid. J. Comp. Neurol. 1949; 91: 337
   PubMed Web of Science ®Google Scholar
• Acton H. W. An investigation into the causation of lathyrism in man. Indian Med. Gaz. 1922; 57: 241
   Google Scholar
• Filimonoff I. N. Zur pathologisch-anatomischen charakteristik des Lathyrismus. Z. Gesamte Neurol. Psychiatr. 1926; 105: 76
   Google Scholar
• Singh M., Singh G. Lathyrism. J. Nerv. Ment Dis. 1952; 116: 923
   PubMed Web of Science ®Google Scholar
• Stockman R. The poisonous principle ofLathyrus and some other leguminous plants. J. Hyg. 1931; 31: 550
   PubMedGoogle Scholar
• Acton H. W., Chopra R. N. The production and pharmacological action of Khesari amine. Indian Med. Gaz. 1922; 52: 412
   Google Scholar
• Stockman R., Johnson J. M. Cereal food poisoning and its relation to the etiology of pellagra. J. Hyg. 1933; 33: 204
   PubMedGoogle Scholar
• Gopalan S. C. The Lathyrus syndrome. Trans. R. Soc. Trop. Med. Hyg. 1950; 44: 333
   PubMed Web of Science ®Google Scholar
• Geiger B. J., Steenbock H., Parsons H. T. Lathyrism in the rat. J. Nutr. 1933; 3: 427
   Google Scholar
• Vivanco F., Jimenez Diaz C. Nuevos estudios sobre los effectos de la proteinas de las legumbres (leguminismos). El laterismo odorato (odoratismo). Rev. Clin. Esp. 1951; 40: 157
   PubMedGoogle Scholar
• McKay G. F., Lalich J. J., Schilling E. D., Strong F. M. A crystalline “lathyrus factor” from Lathyrus odoratus. Arch. Biochem. Biophys. 1954; 52: 313
   PubMed Web of Science ®Google Scholar
• Backhuber T. E., Lalich J. J., Angevine D. M., Schilling E. D., Strong F. M. Lathyius factor activity of beta-amino-propionitrilo and related compounds. Proc. Soc. Exp. Biol. Med. 1955; 89: 294
   PubMedGoogle Scholar
• Hartmann H. A., Lalich J. J., Akert K. Lesions in the anterior motor horn cells of rats after the administration of bis-β-cyanoethylamine. J. Neuropathol. Exp. Neurol. 1958; 17: 298
   PubMed Web of Science ®Google Scholar
• Ule G. Zur ultrastruktur derGhost cells beim Experimentcllen Neurolathyrismus der Ratte, Z. Zellforsch. Mikrosk. Anat. 1962; 56: 130
   PubMedGoogle Scholar
• Chou S-M., Hartmann H. A. Axonal lesions and waltzing syndrome after IDPN administration in rats, with a concept “axostasis,”. Acta Neuropathol. (Berl.) 1964; 3: 428
   PubMedGoogle Scholar
• Chou S-M., Hartmann H. A. Electron microscopy of focal neuroaxonal lesions produced by ββ'-imino-pro-prionitrile in rats. Acta Neuropathol. (Berl.) 1965; 4: 590
   PubMedGoogle Scholar
• Mollitor H., Graessle O. E., Kuna S., Mushett C. W., Sibler R. H. Some toxicological and pharmacological properties of streptomycin. J. Pharmacol. Exp. Ther. 1946; 86: 151
   PubMed Web of Science ®Google Scholar
• Stevenson L. D., Alvord E. C., Correll J. W. Degeneration and necrosis of neurones in eighth cranial nuclei caused by streptomycin. Proc. Soc. Exp. Biol. Med. 1947; 65: 86
   PubMed Web of Science ®Google Scholar
• Wersäll J., Hawkins J. E., Jr. The vestibular sensory epithelia in the cat and their reactions in chronic streptomycin intoxication. Acta Otolaryngol. (Slockh.) 1962; 54: 1
   PubMedGoogle Scholar
• Tyberghein J. Influence of some streptomyces antibiotics on the cochlea microphonics in the ginuea-pig. Acta Otolaryngol. (Stockh.) 1962, Suppl., 171
   Google Scholar
• Duvall A. J., Wersäll J. Site of action of streptomycin upon inner ear sensory cells. Acta Otolaryngol. (Stockh.) 1964; 57: 581
   PubMedGoogle Scholar
• Buxton P. H., Hayward M. Polyneuritis cranialis associated with industrial trichlorethylene poisoning. J. Neural. Neurosurg. Psychiatry 1967; 30: 511
   PubMed Web of Science ®Google Scholar
• Feldman R. G., Meyer R. M., Taub A. Evidence for peripheral neurotoxic effect of trichloroethylene. Neurology (Minneap.) 1970; 20: 599
   PubMed Web of Science ®Google Scholar
• Broser F., Henschler D., Hopf H. C. Chlorierte Acetylene als Ursache enier irreparablen Trigeminusstörung bei zwei Patienten. Dtsch. Z. Nervenheilkd. 1970; 197: 163
   PubMedGoogle Scholar
• Herskowitz A., Lshii N., Schaumberg H. n -Hexane neuropathy. N. Engl. J. Med. 1971; 285: 82
   PubMed Web of Science ®Google Scholar
• Murai Y., Kuroiwa Y. Peripheral neuropathy in chlorobiphenyl poisoning. Neurology (Minneap.) 1971; 21: 1173
   PubMed Web of Science ®Google Scholar
• Magee P. N., Stoner H. B., Barnes J. M. The experimental production of oedema in the central nervous system of the rat by triethyl tin compounds. J. Pathol. Bacteriol. 1957; 73: 107
   Google Scholar
• Aleu F. P., Katzman R., Terry R. D. Fine structure and electrolyte analysis of cerebral oedema induced by alkyl-tin intoxication. J. Neuropathol. Exp. Neurol. 1963; 22: 403
   PubMed Web of Science ®Google Scholar
• Katzman R., Aleu F. P., Wilson C. Further observations on triethyltin edema. Arch. Neurol. 1963; 9: 178
   PubMedGoogle Scholar
• Torak R., Gordon J., Prokop J. Pathophysiology of acute triethyl tin intoxication. Int. Rev. Neurobiol. 1970; 12: 45
   PubMedGoogle Scholar
• Aldridge W. N., Cremer J. E. The biochemistry of organotin compounds: diethyltin chloride and triethyltin sulphate. Biochem. J. 1955; 61: 406
   PubMed Web of Science ®Google Scholar
• Gump W. S. Toxicological properties of hexa-chlorophene. J. Soc. Cosmet. Chem. 1969; 20: 173
   Web of Science ®Google Scholar
• Kimbrough R. D., Gaines T. B. Hexachlorophene effects upon the rat brain. Environ. Health 1971; 23: 114
   Google Scholar
• Carlton W. W. Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. Life Sci. 1967; 6: 11
   PubMedGoogle Scholar
• Blakemore W. F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1973; 1: 413
   Google Scholar
• Pope C. G. Diphtheria toxin and anti-toxin. A short review of progress since the work of Ehrlich. Int. Arch. Allergy Appl. Immunol. 1954; 5: 115
   PubMedGoogle Scholar
• Barksdale L. Lysogenic conversions in bacteria. Bacteriol. Rev. 1959; 23: 202
   PubMedGoogle Scholar
• Lwoff A. The dynamics of viral functions. Proc. R. Soc. Lond. (Biol) 1961; 154: 1
   Web of Science ®Google Scholar
• Cavanagh J. B., Jacobs J. M. Some quantitative aspects of diphtheritic neuropathy. Br. J. Exp. Pathol. 1964; 45: 309
   PubMedGoogle Scholar
• Walshe F. M. R. On the pathogenesis of diphtheritic neuropathy. Q. J. Med. 1918; 12: 14–19
   Google Scholar
• Gaskill H. S., Korb M. Occurrence of multiple neuritis in cases of diphtheria. Arch. Neurol. Psychiatr. (Chicago) 1946; 55: 559
   PubMedGoogle Scholar
• Vizoso A. D., Young J. Z. Internode length and fibre diameter in developing and regenerating nerves. J. Anat. 1948; 82: 110
   Web of Science ®Google Scholar
• Vizoso A. D. The relationship between internodal length and growth in human nerves. J. Anat. 1950; 84: 342
   PubMed Web of Science ®Google Scholar
• Jacobs J. M., Cavanagh J. B., Mellick R. S. Intraneural injection of diphtheria toxin. Br. J. Exp. Pathol. 1966; 47: 507
   PubMedGoogle Scholar
• Allt G., Cavanagh J. B. Ultrastructural changes in the region of the node of Ranvier in the rat caused by diphtheria toxin. Brain 1969; 92: 459
   PubMed Web of Science ®Google Scholar
• Waksman B. H., Adams R. D., Mansmann H. C. Experimental study of diphtheritic polyneuritis in the rabbit and guinea-pig. J. Exp. Med. 1957; 105: 591
   PubMed Web of Science ®Google Scholar
• McDonald W. I. Conduction in muscle afferent fibres during expermental demyelination in cat nerve. Acta Neuropathol. (Berl.) 1962; 1: 425
   Google Scholar
• Meyer P. Anatomische Untersuchungen über Diphtheritische Lähmung. Virchow's Arch. Pathol. Anat. 1881; 85: 181
   Google Scholar
• Fisher C. M., Adams R. D. Diphtheritic paralysis: a pathological study. J. Neuropathol. Exp. Neurol. 1956; 15: 243
   PubMed Web of Science ®Google Scholar
• Papenheimer A. M., Jr., Williams C. M. The effects of diphtheria toxin on thececropia silkworm. J. Gen. Physiol. 1951–52; 35: 727
   Web of Science ®Google Scholar
• Strauss N., Hendee E. D. The effect of diphtheria toxin on the metabolism of HeLa cells. J. Exp. Med. 1959; 109: 145
   PubMed Web of Science ®Google Scholar
• Collier R. J., Pappenheimer A. M., Jr. Studies on the mode of action of diphtheria toxin. I. Phosphorylated intermediates in normal and intoxicated HeLa cells. J. Exp. Med. 1964; 120: 1007
   PubMed Web of Science ®Google Scholar
• Collier R. J., Pappenheimer A. M., Jr. Studies on the mode of action of diphtheria toxin. II. Effect of toxin on amino acid incorporation in cell free systems. J. Exp. Med. 1964; 120: 1019
   PubMed Web of Science ®Google Scholar
• Kato I. Mode of action of diphtheria toxin on protein synthesis. I. Effect of diphtheria toxin on C14 amino acid incorporation into microsomes and mitrochondriain vitro. Jap. J. Exp. Med. 1962; 32: 335
   PubMedGoogle Scholar
• Strauss N. The effect of diphtheria toxin on the metabolism of HeLa cells. II. Effect on nucleic acid metabolism. J. Exp. Med. 1960; 112: 351
   PubMed Web of Science ®Google Scholar
• Bonventre P. F., Imhoff J. G. Studies on the mode of action of diphtheria toxin. I. Protein synthesis in guinea pig tissues. J. Exp. Med. 1966; 124: 1107
   PubMed Web of Science ®Google Scholar
• Matheson D. F. Incorporation of (14C)-glycine into protein of the adult rat peripheral nerve: effects of inhibitors. J. Neurochem. 1968; 15: 179
   PubMed Web of Science ®Google Scholar
• Collier R. J. Effect of diphtheria toxin on protein synthesis: inactivation of one of the transfer factors. J. Mol. Biol. 1967; 25: 83
   PubMed Web of Science ®Google Scholar
• Pleasure D. E., Feldman B., Prockup D. J. Diphtheria toxin inhibits the synthesis of myelin proteolipid and basic proteins by peripheral nervesin vitro. J. Neurochem. 1973; 20: 81
   PubMed Web of Science ®Google Scholar
• Fullerton P. M. Chronic peripheral neuropathy produced by lead poisoning in guinea pigs. J. Neuropathol. Exp. Neurol. 1966; 25: 214
   PubMed Web of Science ®Google Scholar
• Shimazono J. Ueber das Verhalter der zentralen und peripheren Nervensubstanz bei verschiedenen Vergiftungen und Ernåhrungstörungen. Arch. Psychiatr. 1914; 53: 972
   Google Scholar
• De Villaverde J. M. Sur l'avenir des parties constitutives de la fibre nerveuse dans l'intoxication expérimentale par le plomb. Trav. Lab. Recherches Biol. Univ. Madr. 1929; 26: 163–30
   Google Scholar
• McHowell J. C. Nutrition and the nervous system in farm animals. World Rev. Nutr. Diet. 1970; 12: 377
   PubMedGoogle Scholar
• Blakemore W. F. 1972, personal communication
   Google Scholar
• Schlaepfer W. W. Experimental lead neuropathy: disease of the supporting cells in the peripheral nervous system. J. Neuropathol. Exp. Neurol. 1969; 28: 401
   PubMed Web of Science ®Google Scholar
• Ord M. G., Stocken L. A. Metabolic properties of histones from rat liver and thymus gland. Biochem. J. 1966; 98: 888
   PubMed Web of Science ®Google Scholar
• Pogo B. G. T., Pogo A. O., Allfrey V. G., Mirsky A. E. Changing patterns of histone alkylation and RNA synthesis in regeneration of the liver. Proc. Natl. Acad. Sci. U.S.A. 1968; 59: 1337
   PubMed Web of Science ®Google Scholar
• Baldwin G. S., Carnegie P. R. Specific enzymic methylation of an arginine in the experimental allergic encephalomyelitis protein from human myelin. Science 1971; 171: 579
   PubMed Web of Science ®Google Scholar